OrbusNeich Medical Group Holdings' (HKG:6929) attributable profit fell 25% to $18.8 million in the first half from $25.2 million in the year-ago period, according to a Friday filing with the Hong Kong Stock Exchange.
Earnings per share at the medical device company decreased to $0.0228 from $0.0303 in the previous year.
Revenue declined 3.1% to $78.9 million from $81.4 million a year earlier, due to a decline in sales volume in the US and China.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments